ReviewImmunoTargets and therapy2020

All are Equal, Some are More Equal: Targeting IL 12 and 23 in IBD - A Clinical Perspective.

André Jefremow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.